This inventor holds 2 USPTO granted patents. Top assignees: Agence Nationale De Valorisation De La Recherche (Anvar), National Institute of Health and Medical Research. Active years: 1981-1987.
Company Filing History:
1 out of 338 
1 out of 1,853 
Years Active: 1981-1987
Title: The Innovations of Didier Blanot
Introduction
Didier Blanot is a notable inventor based in Bures S. Yvette, France. He has made significant contributions to the field of peptide compounds, particularly those with therapeutic applications. With a total of 2 patents, his work has implications in medical research and treatment.
Latest Patents
One of Didier Blanot's latest patents involves metal polypeptides. This invention relates to novel peptide compounds that share a chemical structure with a polypeptide hormone exhibiting thymic activity, which is isolated from pig blood serum. The application of these compounds is aimed at therapeutic purposes. Additionally, this invention includes intermediates that are useful in preparing the active compounds. Another significant patent focuses on novel polypeptides that possess thymic activity or antagonistic activity. This invention addresses the synthesis processes of these polypeptides, which have specific sequences that contribute to their functionality.
Career Highlights
Throughout his career, Didier Blanot has worked with prominent organizations such as the Agence Nationale de Valorisation de la Recherche (ANVAR) and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Didier Blanot has collaborated with esteemed colleagues, including Jean-François Bach and Mireille Dardenne. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Didier Blanot's contributions to the field of peptide compounds and his innovative patents highlight his role as a significant inventor in medical research. His work continues to influence therapeutic applications and advancements in the scientific community.